These data indicated that HDAC3/NF-κB-p65 and HDAC6/c-Myc were novel signaling pathways beside FLT3/c-Myc selectively promoting the AML progression and contributing to the transformed phenotype of AML. The gene discussed is HDAC6; the disease is acute myeloid leukemia.